Genetic engineering technologies capable of modifying human traits exist today, and their integration with artificial intelligence is accelerating the potential for human enhancement. While these tools offer prospects for medical breakthroughs, they simultaneously raise significant ethical concerns regarding the creation of a tiered society where economic status dictates biological advantages.
The Current State of Human Genetic Engineering
Genetic engineering tools currently allow for the modification of biological traits in human embryos.
The Risk of Biological Inequality
The primary societal concern regarding human genetic engineering is the potential for unequal access. Because these services are costly and likely to remain in the private sector, there is a risk that genetic enhancements will become a luxury good.
Daron Acemoglu has noted that without policy interventions, the world faces a trajectory toward a "tiered society." In this scenario, economic privilege translates directly into biological advantage. If only the wealthy can afford to select or engineer progeny for health, physical endurance, or cognitive performance, these advantages could become hereditary, effectively cementing socioeconomic divisions into the human genome.
Ethical Frameworks and Public Policy
The ethical landscape surrounding gene editing is often compared to the rapid development of AI, yet some scholars argue that the regulatory path for biotechnology is more manageable.
Treating gene editing as a public health measure—rather than a commercial service—could theoretically ensure that the benefits of the technology are distributed equitably, mitigating the risk of creating a genetically stratified population.